Gene · 2213
NIH grants2,625
NIH grants whose papers are about the gene, through NIH's grant-paper links.
241 to 260 of 2,625
Download this page as JSON| Grant | Title | FCGR2B papers | Newest fiscal year |
|---|---|---|---|
| R01AI099195 | Role of ncRNA Surveillance Complex "RNA Exosome" in Class Switch Recombination and Somatic Hypermutation | 1 | 2025 |
| R01AI109644 | Cbfb in RORgt-regulated T cell function | 1 | 2025 |
| R01AI119006 | Clonal Dynamics of the antibody response | 1 | 2025 |
| R01AI121080 | CTCF in CD8 T cell homeostasis and anti-viral/tumor immunity | 1 | 2025 |
| R01AI124690 | Unraveling yellow fever 17D vaccine attenuation: The role of type I interferon and innate immunity | 1 | 2025 |
| R01AI130025 | Role of the gender biased transcription factor VGLL3 in promoting autoimmune responses in SLE | 1 | 2025 |
| R01AI130227 | Targeting Influenza A Virus by a Carbohydrate-inspired Strategy | 1 | 2025 |
| R01AI130379 | Role of the prostaglandin D2 receptor CRTH2 in helminth-induced type 2 inflammation in the intestine | 1 | 2025 |
| R01AI136621 | Dissecting Polyclonal Sera to Reveal Correlates of Productive Immune Responses to HIV | 1 | 2025 |
| R01AI145687 | Structural definition of CD4-induced HIV-1 Env conformational changes required for infection | 1 | 2025 |
| R01AI146581 | Modeling Antibody-induced Immune Responses by NK cells in Mice and Humans (Resubmission 1) | 1 | 2025 |
| R01AI148416 | Histone Variant H3.3 as a Transcription Rheostat in the Immune System | 1 | 2025 |
| R01AI150664 | Origin and Function of Double Negative T cells in Lupus | 1 | 2025 |
| R01AI153425 | Defining conserved epitopes on polymorphic malaria antigens | 1 | 2025 |
| R01AI153830 | Mechanisms driving extrafollicular polyreactive B cell lineages in partial RAG deficiency | 1 | 2025 |
| R01AI155653 | Mechanisms of B cell responses to particulate antigens | 1 | 2025 |
| R01AI155668 | Comprehensive antigenic mapping of the human anti-peanut IgE antibody response | 1 | 2025 |
| R01AI158617 | A systems immunology approach for predicting poor responses to Hepatitis B vaccination | 1 | 2025 |
| R01AI163045 | Mechanism and function of transplacental IgD | 1 | 2025 |
| R01AI165079 | Targeting Siglec-9/Sialoglycan Interactions to Enhance NK Functions During HIV Infection | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/grants?page=13